Trial Profile
Phase I study of CP404 in patients with obesity
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Apr 2016
Price :
$35
*
At a glance
- Drugs CP 404 (Primary)
- Indications Obesity
- Focus Adverse reactions
- 25 Apr 2016 New trial record